nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Vinca Alkaloids—Vincristine—sarcoma	0.311	1	CiPCiCtD
Vinorelbine—Vincristine—sarcoma	0.236	1	CrCtD
Vinorelbine—lung cancer—sarcoma	0.126	1	CtDrD
Vinorelbine—Vindesine—Vincristine—sarcoma	0.0554	0.379	CrCrCtD
Vinorelbine—Vinblastine—Vincristine—sarcoma	0.0554	0.379	CrCrCtD
Vinorelbine—Voacamine—Vincristine—sarcoma	0.0354	0.242	CrCrCtD
Vinorelbine—TUBB4A—Vincristine—sarcoma	0.0156	0.109	CbGbCtD
Vinorelbine—TUBB8—Vincristine—sarcoma	0.0156	0.109	CbGbCtD
Vinorelbine—TUBB2B—Vincristine—sarcoma	0.0156	0.109	CbGbCtD
Vinorelbine—TUBB3—Vincristine—sarcoma	0.0156	0.109	CbGbCtD
Vinorelbine—TUBB2A—Vincristine—sarcoma	0.0156	0.109	CbGbCtD
Vinorelbine—TUBB6—Vincristine—sarcoma	0.0156	0.109	CbGbCtD
Vinorelbine—TUBB—Vincristine—sarcoma	0.013	0.0915	CbGbCtD
Vinorelbine—TUBB1—Vincristine—sarcoma	0.013	0.0915	CbGbCtD
Vinorelbine—TUBB4B—Vincristine—sarcoma	0.013	0.0915	CbGbCtD
Vinorelbine—CYP3A4—Thiotepa—sarcoma	0.00188	0.0132	CbGbCtD
Vinorelbine—ABCB1—Dactinomycin—sarcoma	0.0015	0.0106	CbGbCtD
Vinorelbine—ABCB1—Mitoxantrone—sarcoma	0.00135	0.00946	CbGbCtD
Vinorelbine—ABCB1—Vincristine—sarcoma	0.000926	0.00651	CbGbCtD
Vinorelbine—ABCB1—Etoposide—sarcoma	0.000849	0.00597	CbGbCtD
Vinorelbine—CYP3A4—Mitoxantrone—sarcoma	0.000806	0.00567	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—sarcoma	0.000579	0.00407	CbGbCtD
Vinorelbine—CYP3A4—Vincristine—sarcoma	0.000555	0.0039	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—sarcoma	0.000545	0.00384	CbGbCtD
Vinorelbine—Vinblastine—JUN—sarcoma	0.00054	1	CrCbGaD
Vinorelbine—CYP3A4—Etoposide—sarcoma	0.000509	0.00358	CbGbCtD
Vinorelbine—CYP3A4—Doxorubicin—sarcoma	0.000347	0.00244	CbGbCtD
Vinorelbine—TUBB3—hematopoietic system—sarcoma	0.000252	0.0261	CbGeAlD
Vinorelbine—TUBB1—hematopoietic system—sarcoma	0.000246	0.0255	CbGeAlD
Vinorelbine—TUBB3—connective tissue—sarcoma	0.000243	0.0251	CbGeAlD
Vinorelbine—TUBB6—mammary gland—sarcoma	0.000226	0.0234	CbGeAlD
Vinorelbine—TUBB8—testis—sarcoma	0.000202	0.0209	CbGeAlD
Vinorelbine—TUBB4B—mammary gland—sarcoma	0.000196	0.0203	CbGeAlD
Vinorelbine—TUBB3—lymphoid tissue—sarcoma	0.000177	0.0183	CbGeAlD
Vinorelbine—TUBB2B—myometrium—sarcoma	0.000173	0.0179	CbGeAlD
Vinorelbine—TUBB4A—embryo—sarcoma	0.000172	0.0178	CbGeAlD
Vinorelbine—TUBB—myometrium—sarcoma	0.000163	0.0169	CbGeAlD
Vinorelbine—TUBB2A—myometrium—sarcoma	0.000162	0.0168	CbGeAlD
Vinorelbine—TUBB6—myometrium—sarcoma	0.00016	0.0166	CbGeAlD
Vinorelbine—TUBB1—bone marrow—sarcoma	0.000158	0.0163	CbGeAlD
Vinorelbine—TUBB2B—seminal vesicle—sarcoma	0.000156	0.0161	CbGeAlD
Vinorelbine—TUBB4A—hematopoietic system—sarcoma	0.000153	0.0159	CbGeAlD
Vinorelbine—TUBB4A—connective tissue—sarcoma	0.000148	0.0153	CbGeAlD
Vinorelbine—TUBB—seminal vesicle—sarcoma	0.000148	0.0153	CbGeAlD
Vinorelbine—TUBB2A—seminal vesicle—sarcoma	0.000147	0.0152	CbGeAlD
Vinorelbine—TUBB6—seminal vesicle—sarcoma	0.000145	0.015	CbGeAlD
Vinorelbine—TUBB2B—connective tissue—sarcoma	0.000143	0.0148	CbGeAlD
Vinorelbine—TUBB2A—hematopoietic system—sarcoma	0.000139	0.0144	CbGeAlD
Vinorelbine—TUBB4B—myometrium—sarcoma	0.000139	0.0144	CbGeAlD
Vinorelbine—TUBB3—testis—sarcoma	0.000138	0.0143	CbGeAlD
Vinorelbine—TUBB6—hematopoietic system—sarcoma	0.000138	0.0142	CbGeAlD
Vinorelbine—TUBB1—testis—sarcoma	0.000135	0.014	CbGeAlD
Vinorelbine—TUBB2A—connective tissue—sarcoma	0.000134	0.0139	CbGeAlD
Vinorelbine—TUBB4B—embryo—sarcoma	0.000134	0.0139	CbGeAlD
Vinorelbine—TUBB4A—skin of body—sarcoma	0.000133	0.0138	CbGeAlD
Vinorelbine—TUBB4B—seminal vesicle—sarcoma	0.000126	0.013	CbGeAlD
Vinorelbine—TUBB—smooth muscle tissue—sarcoma	0.000124	0.0128	CbGeAlD
Vinorelbine—TUBB2A—smooth muscle tissue—sarcoma	0.000123	0.0127	CbGeAlD
Vinorelbine—TUBB2A—skin of body—sarcoma	0.000121	0.0125	CbGeAlD
Vinorelbine—TUBB6—smooth muscle tissue—sarcoma	0.000121	0.0125	CbGeAlD
Vinorelbine—TUBB6—skin of body—sarcoma	0.00012	0.0124	CbGeAlD
Vinorelbine—TUBB4B—hematopoietic system—sarcoma	0.00012	0.0124	CbGeAlD
Vinorelbine—TUBB4A—uterus—sarcoma	0.000116	0.012	CbGeAlD
Vinorelbine—TUBB4B—connective tissue—sarcoma	0.000115	0.0119	CbGeAlD
Vinorelbine—TUBB2B—cardiac atrium—sarcoma	0.000113	0.0116	CbGeAlD
Vinorelbine—TUBB4A—lymphoid tissue—sarcoma	0.000108	0.0112	CbGeAlD
Vinorelbine—TUBB—cardiac atrium—sarcoma	0.000106	0.011	CbGeAlD
Vinorelbine—TUBB—uterus—sarcoma	0.000106	0.011	CbGeAlD
Vinorelbine—TUBB2A—cardiac atrium—sarcoma	0.000106	0.011	CbGeAlD
Vinorelbine—TUBB2A—uterus—sarcoma	0.000105	0.0109	CbGeAlD
Vinorelbine—TUBB4B—smooth muscle tissue—sarcoma	0.000105	0.0109	CbGeAlD
Vinorelbine—TUBB6—cardiac atrium—sarcoma	0.000104	0.0108	CbGeAlD
Vinorelbine—TUBB4B—skin of body—sarcoma	0.000104	0.0108	CbGeAlD
Vinorelbine—TUBB6—uterus—sarcoma	0.000104	0.0107	CbGeAlD
Vinorelbine—TUBB4A—tendon—sarcoma	0.000101	0.0105	CbGeAlD
Vinorelbine—TUBB2B—tendon—sarcoma	9.81e-05	0.0101	CbGeAlD
Vinorelbine—TUBB6—lymphoid tissue—sarcoma	9.69e-05	0.01	CbGeAlD
Vinorelbine—TUBB—tendon—sarcoma	9.28e-05	0.0096	CbGeAlD
Vinorelbine—TUBB2A—tendon—sarcoma	9.23e-05	0.00955	CbGeAlD
Vinorelbine—TUBB6—tendon—sarcoma	9.11e-05	0.00942	CbGeAlD
Vinorelbine—TUBB4B—cardiac atrium—sarcoma	9.08e-05	0.00939	CbGeAlD
Vinorelbine—TUBB4B—uterus—sarcoma	9.03e-05	0.00934	CbGeAlD
Vinorelbine—TUBB—bone marrow—sarcoma	8.99e-05	0.0093	CbGeAlD
Vinorelbine—TUBB2A—bone marrow—sarcoma	8.94e-05	0.00925	CbGeAlD
Vinorelbine—TUBB6—bone marrow—sarcoma	8.82e-05	0.00912	CbGeAlD
Vinorelbine—TUBB4B—lymphoid tissue—sarcoma	8.42e-05	0.00871	CbGeAlD
Vinorelbine—TUBB4A—testis—sarcoma	8.4e-05	0.00869	CbGeAlD
Vinorelbine—TUBB2B—testis—sarcoma	8.12e-05	0.0084	CbGeAlD
Vinorelbine—TUBB4A—liver—sarcoma	7.94e-05	0.00822	CbGeAlD
Vinorelbine—TUBB4B—tendon—sarcoma	7.92e-05	0.00819	CbGeAlD
Vinorelbine—TUBB—testis—sarcoma	7.69e-05	0.00795	CbGeAlD
Vinorelbine—TUBB4B—bone marrow—sarcoma	7.67e-05	0.00793	CbGeAlD
Vinorelbine—TUBB2A—testis—sarcoma	7.64e-05	0.00791	CbGeAlD
Vinorelbine—TUBB6—testis—sarcoma	7.54e-05	0.0078	CbGeAlD
Vinorelbine—TUBB—liver—sarcoma	7.27e-05	0.00752	CbGeAlD
Vinorelbine—TUBB2A—liver—sarcoma	7.23e-05	0.00748	CbGeAlD
Vinorelbine—TUBB6—liver—sarcoma	7.13e-05	0.00737	CbGeAlD
Vinorelbine—TUBB4B—testis—sarcoma	6.55e-05	0.00678	CbGeAlD
Vinorelbine—TUBB4B—liver—sarcoma	6.2e-05	0.00641	CbGeAlD
Vinorelbine—TUBB4A—lymph node—sarcoma	6.09e-05	0.0063	CbGeAlD
Vinorelbine—TUBB2B—lymph node—sarcoma	5.89e-05	0.00609	CbGeAlD
Vinorelbine—TUBB—lymph node—sarcoma	5.57e-05	0.00576	CbGeAlD
Vinorelbine—TUBB2A—lymph node—sarcoma	5.54e-05	0.00573	CbGeAlD
Vinorelbine—TUBB6—lymph node—sarcoma	5.47e-05	0.00565	CbGeAlD
Vinorelbine—CYP3A4—hematopoietic system—sarcoma	4.91e-05	0.00508	CbGeAlD
Vinorelbine—CYP2D6—hematopoietic system—sarcoma	4.84e-05	0.005	CbGeAlD
Vinorelbine—TUBB4B—lymph node—sarcoma	4.75e-05	0.00491	CbGeAlD
Vinorelbine—ABCB1—myometrium—sarcoma	4.05e-05	0.00419	CbGeAlD
Vinorelbine—ABCB1—embryo—sarcoma	3.9e-05	0.00403	CbGeAlD
Vinorelbine—ABCB1—seminal vesicle—sarcoma	3.66e-05	0.00379	CbGeAlD
Vinorelbine—ABCB1—hematopoietic system—sarcoma	3.48e-05	0.0036	CbGeAlD
Vinorelbine—CYP2D6—testis—sarcoma	2.65e-05	0.00274	CbGeAlD
Vinorelbine—ABCB1—uterus—sarcoma	2.63e-05	0.00272	CbGeAlD
Vinorelbine—Ill-defined disorder—Etoposide—sarcoma	2.61e-05	0.000899	CcSEcCtD
Vinorelbine—Anaemia—Etoposide—sarcoma	2.6e-05	0.000896	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Dactinomycin—sarcoma	2.59e-05	0.000894	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Vincristine—sarcoma	2.58e-05	0.00089	CcSEcCtD
Vinorelbine—Hypotension—Mitoxantrone—sarcoma	2.58e-05	0.000889	CcSEcCtD
Vinorelbine—CYP3A4—liver—sarcoma	2.55e-05	0.00263	CbGeAlD
Vinorelbine—Paraesthesia—Vincristine—sarcoma	2.54e-05	0.000877	CcSEcCtD
Vinorelbine—Urticaria—Thiotepa—sarcoma	2.54e-05	0.000875	CcSEcCtD
Vinorelbine—Malaise—Etoposide—sarcoma	2.53e-05	0.000874	CcSEcCtD
Vinorelbine—Dermatitis bullous—Doxorubicin—sarcoma	2.53e-05	0.000874	CcSEcCtD
Vinorelbine—Vertigo—Etoposide—sarcoma	2.52e-05	0.000871	CcSEcCtD
Vinorelbine—Abdominal pain—Thiotepa—sarcoma	2.52e-05	0.000871	CcSEcCtD
Vinorelbine—Body temperature increased—Thiotepa—sarcoma	2.52e-05	0.000871	CcSEcCtD
Vinorelbine—Leukopenia—Etoposide—sarcoma	2.51e-05	0.000868	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	2.51e-05	0.000867	CcSEcCtD
Vinorelbine—CYP2D6—liver—sarcoma	2.51e-05	0.00259	CbGeAlD
Vinorelbine—Abdominal pain—Dactinomycin—sarcoma	2.5e-05	0.000864	CcSEcCtD
Vinorelbine—Body temperature increased—Dactinomycin—sarcoma	2.5e-05	0.000864	CcSEcCtD
Vinorelbine—Cardiac failure—Doxorubicin—sarcoma	2.48e-05	0.000856	CcSEcCtD
Vinorelbine—Paraesthesia—Mitoxantrone—sarcoma	2.47e-05	0.000854	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Doxorubicin—sarcoma	2.47e-05	0.000852	CcSEcCtD
Vinorelbine—Lethargy—Doxorubicin—sarcoma	2.47e-05	0.000852	CcSEcCtD
Vinorelbine—Decreased appetite—Vincristine—sarcoma	2.46e-05	0.000849	CcSEcCtD
Vinorelbine—Dyspnoea—Mitoxantrone—sarcoma	2.46e-05	0.000848	CcSEcCtD
Vinorelbine—Cough—Etoposide—sarcoma	2.45e-05	0.000846	CcSEcCtD
Vinorelbine—Blood creatinine increased—Epirubicin—sarcoma	2.45e-05	0.000845	CcSEcCtD
Vinorelbine—ABCB1—lymphoid tissue—sarcoma	2.45e-05	0.00253	CbGeAlD
Vinorelbine—Gastrointestinal disorder—Vincristine—sarcoma	2.44e-05	0.000843	CcSEcCtD
Vinorelbine—Fatigue—Vincristine—sarcoma	2.44e-05	0.000842	CcSEcCtD
Vinorelbine—Hyponatraemia—Doxorubicin—sarcoma	2.43e-05	0.000838	CcSEcCtD
Vinorelbine—Hypertension—Etoposide—sarcoma	2.42e-05	0.000837	CcSEcCtD
Vinorelbine—Pain—Vincristine—sarcoma	2.42e-05	0.000835	CcSEcCtD
Vinorelbine—Constipation—Vincristine—sarcoma	2.42e-05	0.000835	CcSEcCtD
Vinorelbine—Decreased appetite—Mitoxantrone—sarcoma	2.4e-05	0.000827	CcSEcCtD
Vinorelbine—Chest pain—Etoposide—sarcoma	2.39e-05	0.000825	CcSEcCtD
Vinorelbine—Fatigue—Mitoxantrone—sarcoma	2.38e-05	0.00082	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	2.37e-05	0.00082	CcSEcCtD
Vinorelbine—Discomfort—Etoposide—sarcoma	2.36e-05	0.000815	CcSEcCtD
Vinorelbine—Pain—Mitoxantrone—sarcoma	2.36e-05	0.000813	CcSEcCtD
Vinorelbine—Constipation—Mitoxantrone—sarcoma	2.36e-05	0.000813	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Epirubicin—sarcoma	2.35e-05	0.000813	CcSEcCtD
Vinorelbine—Hypersensitivity—Thiotepa—sarcoma	2.35e-05	0.000811	CcSEcCtD
Vinorelbine—Hypersensitivity—Dactinomycin—sarcoma	2.33e-05	0.000805	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Vincristine—sarcoma	2.31e-05	0.000799	CcSEcCtD
Vinorelbine—Muscular weakness—Epirubicin—sarcoma	2.31e-05	0.000796	CcSEcCtD
Vinorelbine—Anaphylactic shock—Etoposide—sarcoma	2.29e-05	0.000791	CcSEcCtD
Vinorelbine—Asthenia—Thiotepa—sarcoma	2.29e-05	0.00079	CcSEcCtD
Vinorelbine—Infection—Etoposide—sarcoma	2.28e-05	0.000786	CcSEcCtD
Vinorelbine—Asthenia—Dactinomycin—sarcoma	2.27e-05	0.000784	CcSEcCtD
Vinorelbine—Feeling abnormal—Mitoxantrone—sarcoma	2.27e-05	0.000784	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—sarcoma	2.27e-05	0.000782	CcSEcCtD
Vinorelbine—Dysphagia—Epirubicin—sarcoma	2.26e-05	0.00078	CcSEcCtD
Vinorelbine—Pruritus—Thiotepa—sarcoma	2.26e-05	0.000779	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Mitoxantrone—sarcoma	2.25e-05	0.000778	CcSEcCtD
Vinorelbine—Thrombocytopenia—Etoposide—sarcoma	2.24e-05	0.000775	CcSEcCtD
Vinorelbine—Tachycardia—Etoposide—sarcoma	2.24e-05	0.000772	CcSEcCtD
Vinorelbine—Body temperature increased—Vincristine—sarcoma	2.24e-05	0.000772	CcSEcCtD
Vinorelbine—Abdominal pain—Vincristine—sarcoma	2.24e-05	0.000772	CcSEcCtD
Vinorelbine—ABCB1—bone marrow—sarcoma	2.23e-05	0.00231	CbGeAlD
Vinorelbine—Skin disorder—Etoposide—sarcoma	2.23e-05	0.000768	CcSEcCtD
Vinorelbine—Pancreatitis—Epirubicin—sarcoma	2.22e-05	0.000765	CcSEcCtD
Vinorelbine—Angina pectoris—Epirubicin—sarcoma	2.2e-05	0.00076	CcSEcCtD
Vinorelbine—Urticaria—Mitoxantrone—sarcoma	2.19e-05	0.000756	CcSEcCtD
Vinorelbine—Anorexia—Etoposide—sarcoma	2.18e-05	0.000754	CcSEcCtD
Vinorelbine—Diarrhoea—Thiotepa—sarcoma	2.18e-05	0.000754	CcSEcCtD
Vinorelbine—Abdominal pain—Mitoxantrone—sarcoma	2.18e-05	0.000752	CcSEcCtD
Vinorelbine—Body temperature increased—Mitoxantrone—sarcoma	2.18e-05	0.000752	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	2.18e-05	0.000752	CcSEcCtD
Vinorelbine—Diarrhoea—Dactinomycin—sarcoma	2.17e-05	0.000748	CcSEcCtD
Vinorelbine—Pancytopenia—Epirubicin—sarcoma	2.15e-05	0.000741	CcSEcCtD
Vinorelbine—Hypotension—Etoposide—sarcoma	2.14e-05	0.000739	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—sarcoma	2.13e-05	0.000736	CcSEcCtD
Vinorelbine—Neutropenia—Epirubicin—sarcoma	2.11e-05	0.000729	CcSEcCtD
Vinorelbine—Dizziness—Thiotepa—sarcoma	2.11e-05	0.000728	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—sarcoma	2.09e-05	0.000722	CcSEcCtD
Vinorelbine—Hypersensitivity—Vincristine—sarcoma	2.08e-05	0.00072	CcSEcCtD
Vinorelbine—Paraesthesia—Etoposide—sarcoma	2.06e-05	0.00071	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—sarcoma	2.05e-05	0.000707	CcSEcCtD
Vinorelbine—Weight decreased—Epirubicin—sarcoma	2.04e-05	0.000706	CcSEcCtD
Vinorelbine—Dyspnoea—Etoposide—sarcoma	2.04e-05	0.000705	CcSEcCtD
Vinorelbine—Angina pectoris—Doxorubicin—sarcoma	2.04e-05	0.000703	CcSEcCtD
Vinorelbine—Hypersensitivity—Mitoxantrone—sarcoma	2.03e-05	0.000701	CcSEcCtD
Vinorelbine—Asthenia—Vincristine—sarcoma	2.03e-05	0.000701	CcSEcCtD
Vinorelbine—Vomiting—Thiotepa—sarcoma	2.03e-05	0.0007	CcSEcCtD
Vinorelbine—Pneumonia—Epirubicin—sarcoma	2.03e-05	0.000699	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—sarcoma	2.01e-05	0.000695	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—sarcoma	2.01e-05	0.000695	CcSEcCtD
Vinorelbine—Vomiting—Dactinomycin—sarcoma	2.01e-05	0.000695	CcSEcCtD
Vinorelbine—Rash—Thiotepa—sarcoma	2.01e-05	0.000694	CcSEcCtD
Vinorelbine—Dermatitis—Thiotepa—sarcoma	2.01e-05	0.000694	CcSEcCtD
Vinorelbine—Headache—Thiotepa—sarcoma	2e-05	0.00069	CcSEcCtD
Vinorelbine—Rash—Dactinomycin—sarcoma	2e-05	0.000689	CcSEcCtD
Vinorelbine—Decreased appetite—Etoposide—sarcoma	1.99e-05	0.000688	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—sarcoma	1.99e-05	0.000685	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Etoposide—sarcoma	1.98e-05	0.000683	CcSEcCtD
Vinorelbine—Asthenia—Mitoxantrone—sarcoma	1.98e-05	0.000682	CcSEcCtD
Vinorelbine—Fatigue—Etoposide—sarcoma	1.98e-05	0.000682	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—sarcoma	1.97e-05	0.000682	CcSEcCtD
Vinorelbine—Stomatitis—Epirubicin—sarcoma	1.96e-05	0.000678	CcSEcCtD
Vinorelbine—Pain—Etoposide—sarcoma	1.96e-05	0.000677	CcSEcCtD
Vinorelbine—Constipation—Etoposide—sarcoma	1.96e-05	0.000677	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—sarcoma	1.95e-05	0.000675	CcSEcCtD
Vinorelbine—Diarrhoea—Vincristine—sarcoma	1.94e-05	0.000668	CcSEcCtD
Vinorelbine—ABCB1—testis—sarcoma	1.91e-05	0.00197	CbGeAlD
Vinorelbine—Hepatobiliary disease—Epirubicin—sarcoma	1.91e-05	0.000658	CcSEcCtD
Vinorelbine—Nausea—Thiotepa—sarcoma	1.9e-05	0.000654	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—sarcoma	1.89e-05	0.000653	CcSEcCtD
Vinorelbine—Feeling abnormal—Etoposide—sarcoma	1.89e-05	0.000652	CcSEcCtD
Vinorelbine—Diarrhoea—Mitoxantrone—sarcoma	1.89e-05	0.000651	CcSEcCtD
Vinorelbine—Nausea—Dactinomycin—sarcoma	1.88e-05	0.000649	CcSEcCtD
Vinorelbine—Agranulocytosis—Epirubicin—sarcoma	1.88e-05	0.000649	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—sarcoma	1.87e-05	0.000647	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Etoposide—sarcoma	1.87e-05	0.000647	CcSEcCtD
Vinorelbine—Dizziness—Vincristine—sarcoma	1.87e-05	0.000646	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—sarcoma	1.86e-05	0.000643	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—sarcoma	1.86e-05	0.000643	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—sarcoma	1.83e-05	0.000631	CcSEcCtD
Vinorelbine—Urticaria—Etoposide—sarcoma	1.82e-05	0.000629	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—sarcoma	1.82e-05	0.000627	CcSEcCtD
Vinorelbine—Abdominal pain—Etoposide—sarcoma	1.81e-05	0.000625	CcSEcCtD
Vinorelbine—Body temperature increased—Etoposide—sarcoma	1.81e-05	0.000625	CcSEcCtD
Vinorelbine—ABCB1—liver—sarcoma	1.8e-05	0.00186	CbGeAlD
Vinorelbine—Hypoaesthesia—Epirubicin—sarcoma	1.8e-05	0.000621	CcSEcCtD
Vinorelbine—Vomiting—Vincristine—sarcoma	1.8e-05	0.000621	CcSEcCtD
Vinorelbine—Rash—Vincristine—sarcoma	1.78e-05	0.000616	CcSEcCtD
Vinorelbine—Dermatitis—Vincristine—sarcoma	1.78e-05	0.000615	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—sarcoma	1.78e-05	0.000613	CcSEcCtD
Vinorelbine—Headache—Vincristine—sarcoma	1.77e-05	0.000612	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—sarcoma	1.76e-05	0.000609	CcSEcCtD
Vinorelbine—Vomiting—Mitoxantrone—sarcoma	1.75e-05	0.000605	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—sarcoma	1.74e-05	0.0006	CcSEcCtD
Vinorelbine—Rash—Mitoxantrone—sarcoma	1.74e-05	0.0006	CcSEcCtD
Vinorelbine—Dermatitis—Mitoxantrone—sarcoma	1.74e-05	0.000599	CcSEcCtD
Vinorelbine—Headache—Mitoxantrone—sarcoma	1.73e-05	0.000596	CcSEcCtD
Vinorelbine—Hypersensitivity—Etoposide—sarcoma	1.69e-05	0.000583	CcSEcCtD
Vinorelbine—Nausea—Vincristine—sarcoma	1.68e-05	0.00058	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—sarcoma	1.68e-05	0.000579	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—sarcoma	1.68e-05	0.000579	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—sarcoma	1.67e-05	0.000575	CcSEcCtD
Vinorelbine—Asthenia—Etoposide—sarcoma	1.64e-05	0.000568	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—sarcoma	1.64e-05	0.000568	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—sarcoma	1.64e-05	0.000566	CcSEcCtD
Vinorelbine—Nausea—Mitoxantrone—sarcoma	1.64e-05	0.000565	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—sarcoma	1.63e-05	0.000564	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—sarcoma	1.63e-05	0.000563	CcSEcCtD
Vinorelbine—Pruritus—Etoposide—sarcoma	1.62e-05	0.00056	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—sarcoma	1.62e-05	0.000558	CcSEcCtD
Vinorelbine—Alopecia—Epirubicin—sarcoma	1.6e-05	0.000552	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—sarcoma	1.57e-05	0.000543	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—sarcoma	1.57e-05	0.000543	CcSEcCtD
Vinorelbine—Diarrhoea—Etoposide—sarcoma	1.57e-05	0.000541	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—sarcoma	1.55e-05	0.000536	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—sarcoma	1.55e-05	0.000536	CcSEcCtD
Vinorelbine—Back pain—Epirubicin—sarcoma	1.52e-05	0.000526	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—sarcoma	1.52e-05	0.000524	CcSEcCtD
Vinorelbine—Dizziness—Etoposide—sarcoma	1.52e-05	0.000523	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—sarcoma	1.51e-05	0.000522	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—sarcoma	1.51e-05	0.000521	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—sarcoma	1.49e-05	0.000516	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—sarcoma	1.48e-05	0.00051	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—sarcoma	1.46e-05	0.000504	CcSEcCtD
Vinorelbine—Vomiting—Etoposide—sarcoma	1.46e-05	0.000503	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—sarcoma	1.46e-05	0.000503	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—sarcoma	1.46e-05	0.000503	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—sarcoma	1.46e-05	0.000502	CcSEcCtD
Vinorelbine—Rash—Etoposide—sarcoma	1.45e-05	0.000499	CcSEcCtD
Vinorelbine—Dermatitis—Etoposide—sarcoma	1.44e-05	0.000498	CcSEcCtD
Vinorelbine—Headache—Etoposide—sarcoma	1.44e-05	0.000496	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—sarcoma	1.42e-05	0.00049	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—sarcoma	1.41e-05	0.000488	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—sarcoma	1.41e-05	0.000486	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—sarcoma	1.41e-05	0.000486	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—sarcoma	1.39e-05	0.00048	CcSEcCtD
Vinorelbine—ABCB1—lymph node—sarcoma	1.38e-05	0.00143	CbGeAlD
Vinorelbine—Cough—Epirubicin—sarcoma	1.37e-05	0.000474	CcSEcCtD
Vinorelbine—Nausea—Etoposide—sarcoma	1.36e-05	0.00047	CcSEcCtD
Vinorelbine—Hypertension—Epirubicin—sarcoma	1.36e-05	0.000469	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—sarcoma	1.35e-05	0.000467	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—sarcoma	1.35e-05	0.000465	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—sarcoma	1.34e-05	0.000463	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—sarcoma	1.34e-05	0.000463	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—sarcoma	1.34e-05	0.000463	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	1.33e-05	0.000459	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—sarcoma	1.32e-05	0.000457	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—sarcoma	1.31e-05	0.000453	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—sarcoma	1.31e-05	0.000452	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—sarcoma	1.3e-05	0.00045	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—sarcoma	1.29e-05	0.000444	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—sarcoma	1.28e-05	0.000443	CcSEcCtD
Vinorelbine—Infection—Epirubicin—sarcoma	1.28e-05	0.000441	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—sarcoma	1.27e-05	0.000439	CcSEcCtD
Vinorelbine—Nervous system disorder—Epirubicin—sarcoma	1.26e-05	0.000435	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—sarcoma	1.26e-05	0.000434	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—sarcoma	1.26e-05	0.000434	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—sarcoma	1.25e-05	0.000433	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—sarcoma	1.25e-05	0.000431	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—sarcoma	1.24e-05	0.000428	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—sarcoma	1.24e-05	0.000428	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—sarcoma	1.24e-05	0.000428	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	1.23e-05	0.000425	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—sarcoma	1.23e-05	0.000423	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—sarcoma	1.22e-05	0.000423	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—sarcoma	1.2e-05	0.000414	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—sarcoma	1.19e-05	0.00041	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—sarcoma	1.18e-05	0.000408	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—sarcoma	1.17e-05	0.000404	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—sarcoma	1.17e-05	0.000402	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—sarcoma	1.16e-05	0.000402	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—sarcoma	1.16e-05	0.0004	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—sarcoma	1.15e-05	0.000399	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—sarcoma	1.15e-05	0.000398	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—sarcoma	1.15e-05	0.000395	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—sarcoma	1.13e-05	0.000391	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—sarcoma	1.12e-05	0.000386	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—sarcoma	1.11e-05	0.000383	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—sarcoma	1.11e-05	0.000383	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—sarcoma	1.11e-05	0.000382	CcSEcCtD
Vinorelbine—Pain—Epirubicin—sarcoma	1.1e-05	0.000379	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—sarcoma	1.1e-05	0.000379	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—sarcoma	1.08e-05	0.000374	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—sarcoma	1.07e-05	0.000368	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—sarcoma	1.06e-05	0.000366	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—sarcoma	1.06e-05	0.000365	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Epirubicin—sarcoma	1.05e-05	0.000363	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—sarcoma	1.03e-05	0.000357	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—sarcoma	1.03e-05	0.000354	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—sarcoma	1.03e-05	0.000354	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—sarcoma	1.02e-05	0.000352	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—sarcoma	1.02e-05	0.000351	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—sarcoma	1.02e-05	0.000351	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—sarcoma	1.02e-05	0.000351	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—sarcoma	1.02e-05	0.000351	CcSEcCtD
Vinorelbine—Feeling abnormal—Doxorubicin—sarcoma	9.8e-06	0.000338	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—sarcoma	9.72e-06	0.000336	CcSEcCtD
Vinorelbine—Hypersensitivity—Epirubicin—sarcoma	9.47e-06	0.000327	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—sarcoma	9.44e-06	0.000326	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—sarcoma	9.4e-06	0.000324	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—sarcoma	9.4e-06	0.000324	CcSEcCtD
Vinorelbine—Asthenia—Epirubicin—sarcoma	9.22e-06	0.000318	CcSEcCtD
Vinorelbine—Pruritus—Epirubicin—sarcoma	9.09e-06	0.000314	CcSEcCtD
Vinorelbine—Diarrhoea—Epirubicin—sarcoma	8.79e-06	0.000303	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—sarcoma	8.76e-06	0.000302	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—sarcoma	8.53e-06	0.000294	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—sarcoma	8.5e-06	0.000293	CcSEcCtD
Vinorelbine—Pruritus—Doxorubicin—sarcoma	8.41e-06	0.00029	CcSEcCtD
Vinorelbine—Vomiting—Epirubicin—sarcoma	8.17e-06	0.000282	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—sarcoma	8.13e-06	0.000281	CcSEcCtD
Vinorelbine—Rash—Epirubicin—sarcoma	8.1e-06	0.00028	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—sarcoma	8.09e-06	0.000279	CcSEcCtD
Vinorelbine—Headache—Epirubicin—sarcoma	8.05e-06	0.000278	CcSEcCtD
Vinorelbine—Dizziness—Doxorubicin—sarcoma	7.86e-06	0.000271	CcSEcCtD
Vinorelbine—Nausea—Epirubicin—sarcoma	7.63e-06	0.000263	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—sarcoma	7.56e-06	0.000261	CcSEcCtD
Vinorelbine—Rash—Doxorubicin—sarcoma	7.5e-06	0.000259	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—sarcoma	7.49e-06	0.000258	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—sarcoma	7.45e-06	0.000257	CcSEcCtD
Vinorelbine—Nausea—Doxorubicin—sarcoma	7.06e-06	0.000244	CcSEcCtD
